Prolonged antiviral therapy for hepatitis B virus-infected health care workers: A feasible option to prevent work restriction without jeopardizing patient safety

Journal of Viral Hepatitis

Volumn 14, Issue 5, 2007, Pages 350-354

  Buster, E H C J ^a   Van Der Eijk, A A ^a   De Man, R A ^a   Janssen, H L A ^a   Schalm, S W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antiviral treatment; HBV DNA; HCW; Health care worker; Nucleoside analogue

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; TENOFOVIR; VIRUS DNA;

ABSENTEEISM; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; LONG TERM CARE; MALE; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; DNA, VIRAL; GENE DOSAGE; HEALTH PERSONNEL; HEPATITIS B, CHRONIC; HUMANS; VIRAL LOAD; VIREMIA;

EID: 34247092378     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00809.x     Document Type: Article

References (24)

1. Buster EH, van der Eijk AA, Schalm SW. Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral Res 2003; 60: 79-85.
2. Centers for Disease Control. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep 1991; 1-9.
3. Gunson RN, Shouval D, Roggendorf M et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003; 27: 213-230.
4. Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1(8635): 406-410.
5. Zaaijer HL, ter Borg F, Cuypers HT, Hermus MC, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994; 32: 2088-2091.
6. Xu DZ, Yan YP, Choi BC et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-26.
7. Corden S, Ballard AL, Ijaz S et al. HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol 2003; 27: 52-58.
8. Zonneveld M, Nunen AB, Niesters HG, Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10(4): 294-297.
9. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331(18): 1173-1180.
10. Gostin LO. A proposed national policy on health care workers living with HIV/AIDS and other blood-borne pathogens. JAMA 2000; 284: 1965-1970.
11. Lai CL, Rosmawati M, Lao J et al. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 2002; 123: 1831-1838.
12. Marcellin P, Chang TT, Lim SG et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808-816.
13. van Bommel F, Wunsche T, Mauss S et al. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 2004; 40: 1421-1425.
14. Inspectorate of Health. IGZ Bulletin: Prevention Iatrogenic Hepatitis B. The Hague: Ministry of Health, Welfare and Sport, 2002.
15. Pas SD, Fries E, De Man RA, Osterhaus AD, Niesters HG. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 2000; 38: 2897-2901.
16. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 1999; 37: 68-73.
17. Valentine-Thon E, van Loon AM, Schirm J, Reid J, Klapper PE, Cleator GM. European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA. J Clin Microbiol 2001; 39: 4407-4412.
18. Lok AS, Zoulim F, Locarnini S et al. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J Clin Microbiol 2002; 40: 3729-3734.
19. Osterhaus AD, Vos MC, Balk AH et al. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant 1998; 17: 158-166.
20. Schalm SW, van Wijngaarden JK. Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution? J Viral Hepat 2000; 7: 245-249.
21. Buster EH, van der Eijk AA, de Man RA, Schalm SW. Doctor-to-patient transmission of hepatitis B virus: the potential of antiviral therapy for prevention. Scand J Gastroenterol Suppl 2004; 241: 45-49.
22. Gerlich WH. [Hepatitis B and C. Risk of transmission from infected health care workers to patients]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47: 369-378.
23. Tedder RS, Ijaz S, Gilbert N et al. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers. J Med Virol 2002; 68: 505-512.
24. Summers T. Public policy for health care workers infected with the human immunodeficiency virus. JAMA 2001; 285: 882.